STOCKHOLM, May 7, 2018 — In patients who have suffered from a heart attack, a large portion of heart cells die, which may cause heart failure and significant mortality and morbidity. The aim of the collaboration with the global biopharmaceutical company AstraZeneca is to develop new ways of regenerating parts of the heart muscle that have been damaged by a heart attack, using Procella Therapeutics' stem cell technology, as well as novel catheter injection methods, using Smartwise's Extroducer catheter.

High concentrations of B-type natriuretic peptide (BNP) are equally predictive of mortality in patients with and without heart failure, according to a study published May 7 in the Journal of the American College of Cardiology.

Despite conflicting reports, eating as many as a dozen eggs per week does not increase the cardiovascular risk for individuals with prediabetes or type 2 diabetes, according to a new study in the American Journal of Clinical Nutrition.

New research published in JACC: Cardiovascular Interventions shows substantial variation between states for non-acute coronary angiograms, percutaneous coronary interventions and coronary artery bypass graft surgeries.

The use of “virtual wards” may be helpful in preventing death and rehospitalizations for patients with congestive heart failure, according to a study published April 30 in PLOS One.

A new study published in Pediatrics suggests a low-carbohydrate diet can help people with type 1 diabetes control blood sugar levels with lower-than-normal doses of insulin.

A paclitaxel-coated balloon demonstrated significantly higher primary patency rates at 12 months and lower odds of reintervention when compared to uncoated balloon angioplasty for femoropopliteal lesions, according to the first randomized, one-year study of the device.

Kevin Smith, a director known for movies such as “Clerks” and “Chasing Amy,” suffered a massive heart attack in February. Now, months after undergoing emergency surgery to treat 100 percent blockage in his left anterior descending artery, Smith has said marijuana might have helped him survive the ordeal.

An intraoperative imaging and mapping system designed to aid in the ablation of complex cardiac arrhythmias was successfully used for the first time in the United States, according to an article distributed by Penn Medicine.

The FDA has approved the use of Andexxa, the first reversal agent for Factor Xa inhibitors, drug manufacturer Portola Pharmaceuticals announced May 3.